Your browser doesn't support javascript.
loading
Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination.
Jo, Norihide; Hidaka, Yu; Kikuchi, Osamu; Fukahori, Masaru; Sawada, Takeshi; Aoki, Masahiko; Yamamoto, Masaki; Nagao, Miki; Morita, Satoshi; Nakajima, Takako E; Muto, Manabu; Hamazaki, Yoko.
Afiliação
  • Jo N; Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Hidaka Y; Alliance Laboratory for Advanced Medical Research, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
  • Kikuchi O; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Fukahori M; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sawada T; Clinical Bio-Resource Center, Kyoto University Hospital, Kyoto, Japan.
  • Aoki M; Department of Early Clinical Development, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
  • Yamamoto M; Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT), Kyoto University Hospital, Kyoto, Japan.
  • Nagao M; Department of Early Clinical Development, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
  • Morita S; Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT), Kyoto University Hospital, Kyoto, Japan.
  • Nakajima TE; Department of Early Clinical Development, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
  • Muto M; Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT), Kyoto University Hospital, Kyoto, Japan.
  • Hamazaki Y; Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Nat Aging ; 3(1): 82-92, 2023 01.
Article em En | MEDLINE | ID: mdl-37118516

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Nat Aging Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Nat Aging Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão